Track topics on Twitter Track topics that are important to you
Data from a phase II trial of Mucomel (3% melatonin gel) suggest the formulation may reduce the risk of oral mucositis resulting from chemo and radiotherapy for head and neck cancers.
Reuters Health Information
Original Article: Melatonin Gel May Reduce Oral Mucositis From Chemo, RadiationNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...